Page 67 - MemoriaBBN-Eng

www.ciber-bbn.es

• o-m s, r h, v A, o i, r e, J-s m .. A Novel
Most relevant rteGAArtorelluizellidolieromerouliàAPéet Al
Semi-Supervised Methodology for Extracting Tumor Type-Specific MRS Sources in
scientific Human Brain Data.PLoS One. 2013;8(12):e83773.

articles
• delGAdo-Goñi t, CAmPo s, mArtín-sitJAr J, CABAñAs me, sAn seGundo B, Arús C. Assessment
of a 1H high-resolution magic angle spinning NMR spectroscopy procedure for free

sugars quantification in intact plant tissue.Planta. 2013 Aug;238(2):397-413.

• ortuño Je, ledesmA-CArBAyo mJ, simões rv, CAndiotA AP, Arús C, sAntos A. DCE@urLAB:
a dynamic contrast-enhanced MRI pharmacokinetic analysis tool for preclinical data.

BMC Bioinformatics. 2013 Nov 4;14:316.

• AlBert vilAmAlA, PAulo J.G. lisBoA, sAndrA orteGA-mArtorell, AlFredo vellido. Discrimi-
nant Convex Non-negative Matrix Factorization for the classification of human brain

tumoursPattern Recognition Letters. 2013;34(14):1734-1747.

The members of the GABRMN/CIBER-BBN group have participated in the publica-
Highlights
tion of 6 journal papers, one in coordination with the group of Prof. Andrés Santos
which was a higly accessed paper in BMC Bioinformatics. Another publication is in

coordination with CIBEREHD, and two more with clinical personnel whereas two

others are the result of international collaborations. The mean impact factor has
been 3.16 , 83% belong to quartile 1 and 66% to decile 2.

With respect to projects, it is worth highlighting the launch of the Marie Curie
à
Initial Training Network TRANSACT, in which Prof. Carles Arús participates as a

partner, and in which the CIBER-BBN has special visibility as Associated partner to
the network. In terms of funding, the project will bring 234,381.62 Euros in four

years mainly to fund one Early Stage Researcher, hired in July 2013, Mr. Victor
Mocioiu. Participation in this project has also impacted the internationalisation of
è
the CIBER-BBN group, with participation in several project-related international

workshops.
ú
Dr. Carles Aguilera and Dr. Albert Oriol have participated in a total of 18 clinical
trials during 2013.

Four PhD theses have been awarded within the group. Dr. Sandra Ortega pur-

sues her postdoctoral training at the Liverpool John Moores University, at Prof.
ú
Paulo Lisboa’s group. Prof. Carles Ars belongs to the editorial committee of the
Magnetic Resonance Materials in Physics, Biology and Medicine journal and Dr.

Alfredo Vellido was organiser of the 21st European Symposium On Artificial Neural
Networks, Computational Intelligence and Machine Learning Bruges (Belgium).

The ESMRMB society awarded Prof. Carles Ars the Certificate of MR Excellence

in Basic Science.
ò

The Servei de Ressonncia Magntica of the Universitat Autnoma de Barcelona is
part of the joint UAB-CIBER-BBN platform. The services provided by the platform 13
20
include the maintenance of the INTERPRET and eTUMOUR multicentre databases, T
which have allowed technology transfer with contacts Siemens and Samsung.
OR
P
RE
L
A
NU
N
A
N /
B
-B
R
BE
CI

67